Clicky

Oxford Biodynamics Plc(OXBOF)

Description: Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.


Keywords: Medicine Biotechnology Clinical Medicine Disease Immunotherapy Biomarkers Epi Switch

Home Page: www.oxfordbiodynamics.com

3140 Rowan Place
Oxford, OX4 2WB
United Kingdom
Phone: 44 1865 518 910


Officers

Name Title
Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D. CEO & Executive Director
Mr. Paul Leslie Stockdale F.C.A., M.A. CFO & Executive Director
Dr. Alexandre Akoulitchev M.A., Ma (Oxon), Ph.D. Chief Scientific Officer & Executive Director
Mr. Thomas G. Guiel B.A. Chief Operating Officer
David Blum Senior Vice President of Marketing
Dr. Steven Arrivo Senior Vice President of Business & Corporate Development
Dr. Ewan Hunter B.Sc., Ph.D., Ph.D., (KCL) Chief Data Officer
T. Demain Company Secretary

Exchange: PINK

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.529
Price-to-Sales TTM: 17.0381
IPO Date:
Fiscal Year End: September
Full Time Employees: 53
Back to stocks